Overview
Portugal’s score in Policy Context is close to the average. This is a result of Portugal having a relatively strong asthma strategy as well as having severe asthma guidelines, while weak tobacco control laws bring Portugal’s score down. Portugal is amongst the lowest scoring in terms of Access and Care Coverage, attributable to limited access to some treatments, especially biologics, FeNO-based diagnostics and digital therapeutics, though high levels of access to inflammatory phenotyping-based diagnostics and specialist care, as well as unmet needs below the average, bring Portugal’s score up. Portugal scores within the bottom third of countries in the Disease Burden category, with one of the highest estimated societal costs of asthma and percentage of DALYs attributable to asthma. However, Portugal displays a rate of deaths associated with asthma that is below the average.
How does Portugal perform in each category?
Provides further insights into how Portugal scores across each Index category
Portugal takeaways
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in Portugal
Portugal has a limited severe asthma strategy and tobacco control laws
Portugal has low Access and Care Coverage and has among the highest levels of DALYs attributable to asthma
Portugal has high levels of access to inflammatory-phenotyping-based diagnostics and specialist care
Compare Portugal to other countries
Select different countries to see how they scored across each of the 5 categories and overall